Biggest News Aggregation in the World
๐Ÿ“ฐ Allo News

Page 4 - Allo News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allo. Real-time updates on events, politics, business and more.

Allogene Therapeutics (NASDAQ:ALLO) Shares Up 2.2%

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report)’s stock price shot up 2.2% during trading on Wednesday . The stock traded as high as $4.23 and last traded at $4.20. 1,019,834 shares were traded during trading, a decline of 61% from the average session volume of 2,615,178 shares. The stock had previously closed at $4.11. […]
Ensign Peak Advisors Inc Manufacturers Life Insurance Company Allogene Therapeutics Inc Victory Capital Management Inc Great West Life Assurance Co Royal Bank
Source: wkrb13.com

iPhone 11 64GB White - Refurbished product | Allo Allo (United States), iphone 11

IPhone 11 64GB White โ€ข Refurbished to new โ€ข Unlocked all operators โ€ข 36 month warranty โ€ข New battery โ€ข Free delivery 24h. iPhone SE 2 64GB White โ€ข Refurbished to new โ€ข Unlocked all operators โ€ข 36 month warranty โ€ข New
United States Best Buy Stand Aluminium Allo Foldable Notebook Liquid Retina Digital Photography Midnight Green

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Ballo dominates inside, No. 5 Arizona overpowers rival Arizona State 105-60

Arizona State coach Bobby Hurley watched film of No. 5 Arizona and feared the worst. The Wildcats made the nightmare come true, turning the rivals' final Pac-12 game at McKale Center into a blowout. Jaden Bradley scored 21 points, Oumar Ballo dominated inside and Arizona overpowered Arizona State 105-60 on Saturday night a year after suffering heartbreak at home against the Sun Devils.
United States Jaden Bradley Desmond Cambridge Jr Bobby Hurley Adam Miller Oumar Ballo
Source: yahoo.com

Q1 2024 Earnings Estimate for Allogene Therapeutics, Inc. Issued By Zacks Research (NASDAQ:ALLO)

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Research analysts at Zacks Research lifted their Q1 2024 earnings per share estimates for Allogene Therapeutics in a report issued on Tuesday, February 6th. Zacks Research analyst S. Ganoria now expects that the company will earn ($0.48) per share for the quarter, up from their prior forecast […]
Deborahm Messemer Allogene Therapeutics Company Profile Zacks Research Great West Life Assurance Co Manufacturers Life Insurance Company Ieq Capital
Source: wkrb13.com

Allogene Therapeutics (NASDAQ:ALLO) PT Lowered to $10.00 at HC Wainwright

Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price target lowered by HC Wainwright from $12.00 to $10.00 in a report published on Friday, Benzinga reports. The firm currently has a buy rating on the stock. Other analysts have also issued reports about the company. Guggenheim lowered Allogene Therapeutics from a buy rating to a […]
Deborahm Messemer Mcglone Suttner Wealth Management Inc Allogene Therapeutics Inc Victory Capital Management Inc Dorsey Whitney Trust Jpmorgan Chase Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science